Skip to main content
OpenTrials
Completed

NCT Number: NCT03681119

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial

Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dementia Brain Diseases Central Nervous System Diseases Mental Disorders Nervous System Diseases Neurocognitive Disorders

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York University School of Medicine

New York, 10016, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must have dementia as primary diagnosis for admission to hospice
  • Must be newly admitted to a participating hospice
  • Must be 50 years or older

Clinicians:

  • Must be a skilled clinician or home health aide who provides care through an eligible home health agency
  • Must be 18 years or older

Exclusion criteria

Persons with Dementia:

  • None

Clinicians:

  • None

Treatment and study plan

Dementia symptom management at home hospice edition

Behavioral

Quality assurance performance improvement program

Education and Training

Behavioral

Education and training

Primary outcomes

  1. Percentage of Hospice IDT Members Who Complete Required Education and Training

    Time frame: 2 Months

    Percentage of Hospice IDT Members who Complete Required Education and Training

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Collaborators

  • National Institutes of Health (NIH)

Registry information

Official study title

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)

Acronym: HAS-QOL

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Sep 21, 2018
Registry last updated
Aug 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.